Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators

Harish Doppalapudi, James Barrios, Jose Cuellar, Melanie Gannon, Takumi Yamada, Vineet Kumar, William R. Maddox, Vance J. Plumb, Todd M. Brown, H. Tom Mcelderry

Research output: Contribution to journalArticlepeer-review


Background: Real-time estimated longevity has been reported in pacemakers for several years, and was recently introduced in implantable cardioverter-defibrillators (ICDs). Objective: We sought to evaluate the accuracy of this longevity estimate in St. Jude Medical (SJM) ICDs, especially as the device battery approaches depletion. Methods: Among patients with SJM ICDs who underwent generator replacements due to reaching elective replacement indicator (ERI) at our institution, we identified those with devices that provided longevity estimates and reviewed their device interrogations in the 18 months prior to ERI. Significant discrepancy was defined as a difference of more than 12 months between estimated and actual longevity at any point during this period. Results: Forty-six patients with Current/Promote devices formed the study group (40 cardiac resynchronization therapy [CRT] and 6 single/dual chamber). Of these, 34 (74%) had significant discrepancy between estimated and actual longevity (28 CRT and all single/dual). Longevity was significantly overestimated by the device algorithm (mean maximum discrepancy of 18.8 months), more in single/dual than CRT devices (30.5 vs. 17.1 months). Marked discrepancy was seen at voltages ≥2.57 volts, with maximum discrepancy at 2.57 volts (23 months). The overall longevity was higher in the discrepant group of CRT devices than in the nondiscrepant group (67 vs. 61 months, log-rank P = 0.03). Conclusions: There was significant overestimation of longevity in nearly three-fourths of Current/Promote SJM ICDs in the last 18 months prior to ERI. Longevity estimates of SJM ICDs may not be reliable for making clinical decisions on frequency of follow-up, as the battery approaches depletion.

Original languageEnglish (US)
Pages (from-to)552-558
Number of pages7
JournalJournal of cardiovascular electrophysiology
Issue number5
StatePublished - May 2017
Externally publishedYes

Bibliographical note

Funding Information:
The University of Alabama at Birmingham participates in clinical trials funded by St. Jude Medical, Boston Scientific, Medtronic, and Biotronik, and has received fellowship funding from Boston Scientific and Medtronic. Harish Doppalapudi and Takumi Yamada have received speaker honoraria from St. Jude Medical. William R. Maddox has consulting agreements with St. Jude Medical and Boston Scientific. H Tom McElderry has consulting agreements with St. Jude Medical, Boston Scientific, and Medtronic. Other authors: No disclosures.


  • battery longevity
  • battery voltage
  • cardiac resynchronization therapy
  • implantable cardioverter-defibrillator
  • lithium silver vanadium oxide
  • longevity estimate


Dive into the research topics of 'Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators'. Together they form a unique fingerprint.

Cite this